The occurrence of mutations in MLH1 or MSH2 genes leads to an increased risk (70–80%) of developing cancer, while mutations in the MSH6 or PMS2 genes have a comparatively lower risk (25–60%) of cancer development [16]. The gene discussed is MSH2; the disease is cancer.